The largest database of trusted experimental protocols

B6.129s7 ifngtm1ts j

Manufactured by Jackson ImmunoResearch
Sourced in United States, Montenegro

B6.129S7-Ifngtm1Ts/J is a transgenic mouse strain that carries a targeted mutation in the interferon gamma (Ifng) gene. This mouse strain is commonly used in immunological research to study the role of interferon gamma in various biological processes.

Automatically generated - may contain errors

42 protocols using b6.129s7 ifngtm1ts j

1

Mouse Strains for Immunological Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 (wild-type, strain 000664), B6.129S7-Ifngtm1Ts/J (Ifng-/-, strain 002287), B6.129P2-Nos2tm1Lau/J (Nos2-/-, strain 002609), and B6.129S-Csf2tm1Mlg/J (Csf2-/-, strain 026812) were purchased from The Jackson Laboratory and bred in-house. B6.129-Hif1atm3Rsjo/J (Hif1afl/fl, strain 007561) and B6.129P2-Lyz2tm1(cre)Ifo/J (LysMcre, strain 004781) mice were obtained from The Jackson Laboratory, crossed to generate Hif1afl/fl, LysMcre+/+ (referred to here as Hif1a-/-) mice and bred in-house. Ifngr1-/- (Ifngr-/-) mice were provided by D. Raulet. Tnfrsf1a-/-/Tnfrsf1b-/- (Tnfr1/2-/-) mice were provided by G. Barton [50 (link)]. Ifnar-/-/Ifngr1-/- (Ifnar-/-/Ifngr-/-) mice were provided by M. Welch [51 (link)]. Csf2rb-/- mice were provided by S. Shin [52 (link)]. C7 TCR tg.CD90.1 (C7 Tg) mice which express a T cell receptor specific for the M. tuberculosis antigen ESAT-6 were provided by K. Urdahl and have been described previously [53 (link),54 (link)]. H11Cas9 CRISPR/Cas9 knock-in (Cas9 Tg) mice, which constitutively express CRISPR associated protein 9 (Cas9), were provided by R. Vance and were bred to Ifngr-/- mice to generate Ifngr-/-/Cas9 Tg mice.
+ Open protocol
+ Expand
2

Murine Model Characteristics for Immunology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-week-old female C57BL/6 mice were purchased from NCI or Charles River Laboratories. B6.129S2-CD8atm1Mak/J(CD8-deficient), B6.129S7-Ifngtm1Ts/J (IFN-γ-deficient) and C57BL/6-Pfptm1Sdz (perforin-deficient) mice were purchased from Jackson Laboratories. B6.129P2-H2-Kbtm1H2-Dbtm1N12 (MHCI-deficient) mice were purchased from Taconic. gBT-I TCR transgenic mice specific for the glycoprotein B epitope gB(498–505)45 (link) were provided by F.R. Carbone and W.R. Heath and bred in our facility to C57BL/6-Ly5.2Cr mice (CD45.1+) (NCI). Mgl2+/DTR-GFP (Mgl2DTR/GFP) animals have been previously described13 (link). All procedures used in this study complied with federal and institutional policies of the Yale Animal Care and Use Committee.
+ Open protocol
+ Expand
3

Efficacy of BKI1318 in IFN-γ KO Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Efficacy in female IFN-γ KO mice (B6.129S7-Ifngtm1Ts/J; Jackson Laboratories) aged 8–10 weeks was evaluated as previously described [15 (link)]. Beginning on day 6 after infection, mice were dosed with 30 mg/kg BKI1318 suspended in 0.2 mL of vehicle, 15 mg/kg elacridar in 0.1 mL of vehicle followed 15 minutes later by 30 mg/kg BKI1318 in 0.1 mL of vehicle, or 0.2 mL of vehicle only once daily for 5 days. Fecal specimens were collected daily from each group and weighed. Each fecal sample was checked for luminescence on the day of collection, and the number of relative light units was determined and normalized to fecal sample weights.
+ Open protocol
+ Expand
4

Mouse Strain Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
8–12-wk-old female C57BL/6 (CD45.2), B6.SJL-Ptprca Pepcb/BoyJ (CD45.1/Ly5.1), and B6.129S7-Ifngtm1Ts/J mice were either purchased from The Jackson Laboratory or bred and maintained at the University of Florida animal facility. All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Florida (Gainesville, FL; OLAW Assurance # A3377-01).
+ Open protocol
+ Expand
5

Subcutaneous Tumor Establishment in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All in vivo procedures were performed in accordance with the University of Rochester’s University Committee on Animal Resources approved guidelines. Six- to eight-week-old wildtype and age-matched Ifng−/− (B6.129S7-Ifngtm1Ts/J) C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and from a generous gift by Edith Lord, PhD. Animals were given at least one week to acclimate before establishment of subcutaneous tumors.
+ Open protocol
+ Expand
6

Murine Immune Cell Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 (WT), CD45.1 (B6.SJL-PtprcaPepcb/BoyJ), CD90.1 (B6.PL-Thy1a/CyJ), OT-I (C57BL/6-Tg(TcrαTcrβ)1100Mjb/J), TCRα KO (B6.129S2-Tcrαtm1Mom/J), IFNγ KO (B6.129S7-Ifngtm1Ts/J) and TAP KO (B6.129S2-Tap1tm1Arp/J) mice were purchased from Jackson Laboratories (Bar Harbor, ME). Vα2var mice [24 (link)] were bred at Jackson Laboratories (Bar Harbor, ME). Mice were 6 to 10 weeks old at the start of all experiments. Mice infected with M. tuberculosis were housed in a biosafety level 3 facility under specific pathogen-free conditions at DFCI or at UMMS.
+ Open protocol
+ Expand
7

Genetically Modified Mice for iNKT Cell Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6N mice at the age of 6–7 weeks were purchased from NIH/Charles River Laboratories (Wilmington, MA) or Envigo (Indianapolis, IN). Ja281−/− iNKT KO (Ja281 KO) mice with C57BL/6 background were obtained from the National Institutes of Health and bred at Washington State University Wegner Hall Vivarium in Pullman and PBS Vivarium in Spokane. Traj18 KO mice (B6(Cg)-Traj18tm1.1Kro/J), CD45.1 mice (B6.SJL-PtprcaPepcb/BoyJ), IFN-γ KO mice (B6. 129S7-Ifngtm1Ts/J), IL-4 KO mice (C57BL/6-Il4tm1Nnt/J), CXCR6 KO mice (B6.129P2-Cxcr6tm1Litt/J), and IL-17A KO mice (Il17atm1.1(icre)Stck/J) were purchased from Jackson Laboratories (Bar Harbor, ME). IFN-γ/iNKT double KO (dKO) mice were created at Washington State University Wegner Hall Vivarium through crossing Ja281 KO mice with IFN-γ KO mice. Mice were housed in a specific pathogen-free room, in plastic cages with micro-filter tops and CareFresh beddings, and were allowed free access to Purina 5001 rodent laboratory chow and sterilized Milli-Q water. The animal protocols used in this study were approved by the Institutional Animal Care and Use Committee at Washington State University.
+ Open protocol
+ Expand
8

Establishment of IFN-γ KO Mouse Model for C. parvum Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice procedures reported in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Illinois at Urbana-Champaign under protocol numbers 17188 and 20188. Breeder pairs of interferon gamma knock out (IFN-γ KO) mice (B6.129S7-Ifngtm1Ts/J) were purchased from the Jackson laboratory for mating, and an in-house mouse colony was maintained. Four- to 6- week old IFN-γ KO mice (n = 5 mice per cage) were used for generating and passaging stable transgenic C. parvum strain. Both male and female IFN-γ KO mice (age- and sex-matched) were used for infection experiments. Mice infected with C. parvum were monitored for weight loss, fur ruffling, hunched posture and inactivity, and any animal showing a weight loss of ≥= 15% was euthanized.
+ Open protocol
+ Expand
9

Genetically Engineered C. parvum Luciferase Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 5’ UTR and 3’UTR of the C. parvum actin gene was amplified from parasite genomic DNA and ligated into KpnI/ClaI and SpeI/BamHI sites of plasmid TK-Eno-Nluc-Neo-TK 8 (link) respectively. The coding sequence for red-shifted luciferase20 (link) was amplified from pTubRE9 vector (kind gift from Markus Meissner, University of Glasgow) and cloned into SalI/NheI restriction sites replacing Nluc. A 404 bp fragment of the 5’TK flank, the tk gene and a ribosomal 3’UTR was inserted upstream of the 5’ actin UTR using Gibson Assembly cloning (New England Biolabs). The final vector, along with the Cas9 plasmid containing a TK guide RNA (GAAGAATACAATTTCTAAGG) that targets the 3’ end of the tk gene was used to transfect C. parvum sporozoites. Sporozoites were delivered via surgery into the small intestine of C57BL/6 IFN-γ knockout mice (B6.129S7-Ifngtm1Ts/J, Jackson Laboratories) using procedures described previously8 (link). Note that UGA1 Nluc parasites were generated using C. parvum IOWA II oocysts purchased from Sterling Parasitology Laboratory, University of Arizona whereas the UGA2 Fluc strain was engineered using C. parvum IOWA II oocysts purchased from Bunch Grass Farms, Deary, ID.
+ Open protocol
+ Expand
10

Murine Leishmaniasis Immunology Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
B6.CD45.1, B6.CD45.2, (B6.CD45.1xCD45.2)F1, B6.EYFP.Rag1-/- and B6.Rag2-/-.CD45.1Cg were used in this study, bred and maintained under specific-pathogen free (SPF) conditions at the Biological Services Facility, University of York. BM cells from mice lacking the Ifngr2 gene (IFNγ-R2 KO) on a B6 background were generously provided by Dr. Grainger (University of Manchester, UK) [61 (link)]. BM cells from TNF receptor double KO mice (Tnfrsf1-dKO B6.129S mice) [62 ] backcrossed >10 generations to C57BL/6 mice were provided by Dr. Lindbom (Lund University, Sweden). IFNγ-KO (B6.129S7-Ifngtm1Ts/J, stock no. 002287) mice were obtained from the Jackson Laboratory. All mice were between 5–8 weeks of age at the start of experimental work. Mice were infected via the lateral tail vein with 3x107 amastigotes of the Ethiopian strain of L. donovani (LV9) or tandem Tomato fluorescent protein expressing L. donovani (tdTom-L. donovani). Spleen parasite burden was expressed as Leishman-Donovan units (LDU), where LDU was equal to the number of parasites/1000 host nuclei multiplied by the organ weight in milligrams. BM parasite burden was determined as the number of parasites/1000 host nuclei.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!